Fig. 1From: Safety and tolerability of adjunctive rosiglitazone treatment for children with uncomplicated malariaStudy profile of 33 patients screened for eligibility for a randomized, placebo-controlled, phase IIa trial of adjunctive rosiglitazone for the treatment of uncomplicated malaria in childrenBack to article page